Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. - Wikidata - wikimedia - TriplyDB

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q45172988

about

How to select the best available related or unrelated donor of hematopoietic stem cells?What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics Predicting alloreactivity in transplantation.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1 Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.Blood and marrow transplant clinical trials network state of the Science Symposium 2014 A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.A perspective on the selection of unrelated donors and cord blood units for transplantation Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT Role of HLA in Hematopoietic Stem Cell Transplantation.Genetics of graft-versus-host disease: the major histocompatibility complex.Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.On the future of HLA.HLA DNA typing: past, present, and future.Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications.Role of non-HLA gene polymorphisms in graft-versus-host disease.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.In celebration of Ruggero Ceppellini: HLA in transplantation.Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation.Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.Predicting relevant immunogenetic disparities.Allogeneic stem cell transplantation for acute myeloid leukemia.Identification of a novel HLA-DPB1 allele, HLA-DPB1*167:01, in a Chinese individual.In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors.Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin.Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice.Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.HLA-typing analysis following allogeneic bone grafting for sinus lifting.Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation.Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

P2860

Q26744109-C73DA053-5DB1-49BF-8A64-2FDCCF5A2296 Q28075219-51E2E3D0-50E2-4A2C-BFE8-B50B7E119FCE Q33608371-2D8AE8C5-2C60-461B-BC86-DFF74EAE43BE Q33642419-1BD22BD6-0E5C-48BC-9E5A-E19367B7444B Q33689153-FF3E3E39-4A7D-42D3-920B-702A72E1AF3B Q34135396-9A0A9A80-2406-485C-911E-74F4C18F5CC8 Q34353744-657EAA8B-6FBD-44FA-BE70-BBFE503C6EFF Q34749292-74D02533-54FD-463A-A6C3-F6ECD238A93C Q34768153-F8E8E448-1AA7-471D-9D58-2C81EA8DF6E9 Q35591760-92938B72-B97F-4BB6-8625-C3835E317C87 Q36091059-E7148BCE-F0F3-4E97-AFAD-64EA9703DDEA Q36100445-EBD359AC-47CF-47D6-BB7F-763E926A9FCD Q36305321-AE40698F-6185-4C95-BD29-61976774322E Q36307305-7A5A5769-9B3C-40EF-90F2-3EB527B33C85 Q36766250-BE127862-224F-4BFC-94C1-B74C04A1F5A4 Q37268004-BE3F6550-2971-4F84-85D0-02B744B6A747 Q37935058-7BFD36E2-4547-42A3-BABC-F14011AD149F Q38014961-CA54C951-563F-4013-B2DA-7E3FF8263BEB Q38062303-4A9FCF45-0EE7-43D8-8A90-7202265DE346 Q38104375-EC5E3711-7BBE-48E0-92D5-4CA959A7D1CD Q38129337-1D049DC0-32CD-414F-9CFA-FFF61D679784 Q38922475-F4D8F3B3-7F19-4628-9EE0-72A369E1A356 Q39094693-54E827BA-4418-45ED-8079-1C82D0716830 Q39123538-66214191-CE42-4136-A384-F6ED01DE9DCC Q39544554-40EE265E-B85A-4A7B-AF89-C66D4DEFA219 Q40343240-0C6E3628-2E9E-4C50-88C9-78F409AEBE28 Q42428458-9547C2C2-608F-4A4C-A709-955FA40D3292 Q42765065-E7CE8E03-4690-40C0-8B0F-8498C95AAE6F Q44188886-77089CC9-B2C1-492F-9FFE-DB91DEB955FF Q44571503-ECB0FCD3-56AD-4EA4-9802-46848972F9A3 Q46609060-48351DD9-B877-4742-ACD6-73D652B89503 Q47587797-4A8E51F9-2292-482B-B50B-FF173205908B Q47615845-5200D0B7-1D89-4DC6-BB28-9333F48A3677 Q47795034-4B5685F5-5F9F-475B-8359-8113264306A0 Q48162670-F602B3D6-4AFA-45A9-9254-283DFDBA66C4 Q50868968-021F5A10-4ABD-46E6-8163-03BD535FD056 Q51017262-EE8A8C72-D46D-453F-B225-FE7BDDF6AC24 Q51362313-892EE34C-73C0-44A0-BD49-41A8241DA221 Q52620753-57B2039C-27FA-472A-BE94-9C2DAB492870 Q52766742-FC9E12BE-B5DA-4B80-97AF-D7F3197B7B7E

P2860

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q45172988

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@en

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@nl

type

label

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@en

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@nl

prefLabel

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@en

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@nl

P1433

Q45172988-B7FE2A9F-2ED8-434D-8938-E27FC1A1A8F9

P1476

Q45172988-52A19F18-CCFD-4EFB-8CDE-11528F786397

P2093

Q45172988-03D1125A-6206-466F-BB3A-C7430572322F

Q45172988-0CBAFA2C-9DFD-4160-A4BB-1E306BB424A7

Q45172988-23A97D08-A062-44E7-99E6-9FEEC1CBC74E

Q45172988-4605A379-6A45-4843-8C22-56195301D7F3

Q45172988-4ED9A734-73D3-4E3C-90C0-FEDE51DF0881

Q45172988-512B0A8D-19EF-4AF1-9512-F21380B2F512

Q45172988-57875A88-97CA-4133-88B5-981C7D4AA1F8

Q45172988-599FB4D9-F83D-4A3E-9A2F-F22891E5BFF2

Q45172988-6B258CB5-5E53-47E0-B59E-E582B48A3E33

Q45172988-89BC6B5E-627F-4CA8-A91A-9964D6471E53

P304

Q45172988-21BA3B05-BB1D-4FF4-84B4-E74E96BF868F

P31

Q45172988-BB1FCFC3-2A5C-436C-9D21-CC6F6035C89B

P356

Q45172988-3D20AD33-AAED-48F5-9E27-3B4B28EDDBA0

P407

Q45172988-3B193FE6-F0EB-43F9-A748-DB07470A839D

P433

Q45172988-3E93542F-68AC-4CFB-B647-AEDADFBCD9CF

P478

Q45172988-386A908B-8A61-4605-B05E-18C52EB126EF

P50

Q45172988-2b03a0cf-495f-b92d-7fd0-b6f4b94385c4

Q45172988-D7F7012F-BB48-4792-9E2D-AEC4AE9C0224

P577

Q45172988-1ABCA960-C2EE-4B2A-A34B-73FA2DE1F4D5

P5875

Q45172988-726568CD-3388-4DC7-97C9-57257A7E92C5

P698

Q45172988-A088050E-3E06-4855-BC9D-59FEA96C00B7

P921

Q45172988-311C5921-87E6-459D-A40D-DA61B415801A

P356

BLOOD-2009-01-200378

P1433

P1476

Nonpermissive HLA-DPB1 dispari ...... tic stem cell transplantation.

@en

P2093

Alberto Bosi

http://www.w3.org/2001/XMLSchema#string

Andrea Bacigalupo

http://www.w3.org/2001/XMLSchema#string

Barbara Bruno

http://www.w3.org/2001/XMLSchema#string

Elisabetta Zino

http://www.w3.org/2001/XMLSchema#string

Fabio Ciceri

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bandini

http://www.w3.org/2001/XMLSchema#string

Gruppo Italiano Trapianto di M ...... iche (CSE) e Terapia Cellulare

http://www.w3.org/2001/XMLSchema#string

Italian Bone Marrow Donor Registry

http://www.w3.org/2001/XMLSchema#string

Jessica Marcon

http://www.w3.org/2001/XMLSchema#string

Katharina Fleischhauer

http://www.w3.org/2001/XMLSchema#string

P304

1437-1444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-01-200378

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Nicoletta Sacchi

P577

2009-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26281925

http://www.w3.org/2001/XMLSchema#string

P698

19515726

http://www.w3.org/2001/XMLSchema#string

P921